Literature DB >> 26519215

Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality.

Dharmendra Kumar1, Padmaprakash Kadavoor Vadiraja1, Baibaswata Nayak1, Bhaskar Thakur2, Prasenjit Das3, Siddhartha Datta Gupta3, Subrat Kumar Panda3, Subrat Kumar Acharya1.   

Abstract

BACKGROUND AND AIM: Acute on chronic liver failure (ACLF) because of precipitating factors (variceal bleed/infections) identifies cirrhotics at risk for high short-term mortality. Information on ACLF because of acute hepatic insults is lacking. The aim of the study was to evaluate acute hepatic insults in ACLF and their effect on the course and outcome.
METHODS: In a prospective study, 213 consecutive patients of ACLF because of acute hepatic insults were included. Etiology of acute hepatic insult, frequency of silent, and overt chronic liver disease (CLD), organ failure (OF), and outcomes were assessed. Prognostic models such as model for endstage liver disease (MELD), acute physiology and chronic health evaluation (APACHE II), and chronic liver failure-sequential organ failure (CLIF-SOFA) were evaluated.
RESULTS: Etiologies of acute hepatic insult were hepatitis virus(es)- 81 (38%; HBV-42, HEV-39), continuous alcohol consumption-77 (33.3%), antituberculosis drugs-11 (5.2%), autoimmune hepatitis flare-5(2.3%), cryptogenic-44 (20.7%). The common causes of CLD were alcohol (n = 85/40%), HBV(n = 52/24%), and cryptogenic(n = 50/20%). The MELD, APACHE II, and CLIF-SOFA scores were similar among silent and overt CLD and did not influence outcome. Predominant etiologies of ACLF were hepatitis virus(es) reactivation or superinfection in silent CLD(52/112, 46.4%) and alcohol among overt CLD(43/101, 43%). Independent predictors of mortality included hepatic-encephalopathy (early, HR: 4.01; advanced, HR: 6.10), serum creatinine ≥1.5 mg/dl (HR: 4.53), CLIF-SOFA ≥8(HR: 1.69), and etiology of acute hepatic insult (alcohol, HR: 4.08; cryptogenic, HR: 3.18). HEV-ACLF had lower mortality (12.8% vs. 33-54% in other etiologies;P < 0.001). OF was major determinant of mortality. With increasing number of OF, mortality increased linearly(P = 0.001).
CONCLUSIONS: Hepatitis virus(es) and continuous alcohol consumption are important causes of ACLF caused by acute hepatic insults. HEV-ACLF has lower mortality. OF is an important prognostic predictor.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hepatitis e virus; organ failure; silent; superinfection

Mesh:

Substances:

Year:  2016        PMID: 26519215     DOI: 10.1111/jgh.13213

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

1.  Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.

Authors:  Gyanranjan Rout; Sanchit Sharma; Deepak Gunjan; Saurabh Kedia; Anoop Saraya; Baibaswata Nayak; Vishwajeet Singh; Ramesh Kumar
Journal:  Dig Dis Sci       Date:  2019-03-04       Impact factor: 3.199

2.  Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients.

Authors:  Saurabh Kedia; Deepak Gunjan; Ujjwal Sonika; Soumya Jagannath Mahapatra; Baibaswata Nayak; Harpreet Kaur; Subrat Kumar Acharya
Journal:  Dig Dis Sci       Date:  2017-01-27       Impact factor: 3.199

3.  Viral hepatitis: Indian scenario.

Authors:  Sandeep Satsangi; Yogesh K Chawla
Journal:  Med J Armed Forces India       Date:  2016-08-09

4.  How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?

Authors:  Bikrant Bihari Lal; Vikrant Sood; Rajeev Khanna; Seema Alam
Journal:  Hepatol Int       Date:  2018-10-19       Impact factor: 6.047

5.  Liver Transplantation for Acute on Chronic Liver Failure.

Authors:  Narendra S Choudhary; Neeraj Saraf; Sanjiv Saigal; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-08-24

Review 6.  Toward a Better Definition of Acute-on-Chronic Liver Failure.

Authors:  Ajay Duseja; Shivaram P Singh
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

7.  Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.

Authors:  Tao Chen; Zhongyuan Yang; Ashok Kumar Choudhury; Mamun Al Mahtab; Jun Li; Yu Chen; Soek-Siam Tan; Tao Han; Jinhua Hu; Saeed S Hamid; Lee Guan Huei; Hasmik Ghazinian; Yuemin Nan; Yogesh K Chawla; Man-Fung Yuen; Harshad Devarbhavi; Akash Shukla; Zaigham Abbas; Manoj Sahu; A K Dokmeci; Laurentias A Lesmana; Cosmas Rinaldi A Lesmana; Shaojie Xin; Zhongping Duan; Wei Guo; Ke Ma; Zhongwei Zhang; Qiuyu Cheng; Jidong Jia; B C Sharma; Shiv Kumar Sarin; Qin Ning
Journal:  Hepatol Int       Date:  2019-10-24       Impact factor: 6.047

8.  Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome.

Authors:  Ujjwal Sonika; Shekhar Jadaun; Gyan Ranjan; Gyanranjan Rout; Deepak Gunjan; Saurabh Kedia; Baibaswata Nayak
Journal:  Indian J Gastroenterol       Date:  2018-02-23

9.  Acute on Chronic Liver Failure-In-Hospital Predictors of Mortality in ICU.

Authors:  Sujay Kulkarni; Mithun Sharma; Padaki N Rao; Rajesh Gupta; Duvvuru N Reddy
Journal:  J Clin Exp Hepatol       Date:  2017-11-23

Review 10.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.